NCT00321373 - Study to Evaluate an Influenza Vaccine Candidate | Biotech Hunter

Enrollment

1,220

Participants

Timeline

Start Date

May 11, 2006

Primary Completion Date

July 1, 2006

Study Completion Date

July 18, 2006

Conditions

Influenza

Interventions

BIOLOGICAL

Candidate Influenza Vaccine GSK1247446A - 2 different formulations

Single dose, Intramuscular injection

BIOLOGICAL

FluarixTM

Single dose, Intramuscular injection

Trial Locations (17)

15140

GSK Investigational Site, Lahti

20520

GSK Investigational Site, Turku

28120

GSK Investigational Site, Pori

33200

GSK Investigational Site, Tampere

48100

GSK Investigational Site, Kotka

54642

GSK Investigational Site, Thessaloniki

90100

GSK Investigational Site, Oulu

00100

GSK Investigational Site, Helsinki

00930

GSK Investigational Site, Helsinki

04400

GSK Investigational Site, Järvenpää

01300

GSK Investigational Site, Vantaa

01600

GSK Investigational Site, Vantaa

115 27

GSK Investigational Site, Goudi / Athens

124 62

GSK Investigational Site, Haidari

151 26

GSK Investigational Site, Marousi

184 54

GSK Investigational Site, Nikaia Piraeus

682 00

GSK Investigational Site, Orestiáda